MedPath

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

Recruiting
Conditions
Chronic Lymphocytic Leukemia
Relapse Leukemia
Refractory Leukemia
Interventions
Registration Number
NCT04282811
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Brief Summary

Observational study aimed at describing the characteristics and outcome of CLL patients who started treatment with venetoclax-based regimens according to the local label outside clinical trials in Italy in a period of time ranging from the start of the Venetoclax Named Patient Program (March 2016) until June 30th, 2025.

Detailed Description

Observational study to describe the characteristics and outcome of CLL patients treated with venetoclax according to the local label. The study includes two different groups: a retrospective group (all patients who have received at least one dose of venetoclax before enrolment) and a prospective group (patients receiving treatment with venetoclax after enrolment). All patients in both groups will be observed for up to 48 months from the treatment start. In the prospective cohort only, QoL and treatment adherence will be assessed at the time of study entry (i.e. baseline) and thereafter at 3, 6, 9, 12, 18 24, 30, 36, 42 and 48 months of follow-up and at treatment discontinuation (due to any cause).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
321
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
cohort groupVenetoclaxPatients who have received at least one dose of venetoclax
Primary Outcome Measures
NameTimeMethod
Estimation of the PFS in relapsed/refractory (R/R) patients with CLL treated with venetoclax-based regimens according to the local label outside clinical trials in Italy.15 months

Estimation of the PFS at 15 months from the start of venetoclax treatment in patients with R/R CLL who started treatment with venetoclax-based regimens according to the local label from the start of the Venetoclax Named Patient Program (March 2016) until October 31st, 2021

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (27)

Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto

๐Ÿ‡ฎ๐Ÿ‡น

Bari, Italy

Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione

๐Ÿ‡ฎ๐Ÿ‡น

Cona, Ferrara, Italy

Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Alessandria, Italy

Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo

๐Ÿ‡ฎ๐Ÿ‡น

Cagliari, Italy

Ao Di Catanzaro "Pugliese-Ciaccio", Presidio Ospedaliero "Ciaccio - de Lellis" - Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Catanzaro, Italy

Ctc U.O Di Ematologia Con Trapianto Di Midollo Osseo - Catania

๐Ÿ‡ฎ๐Ÿ‡น

Catania, Italy

Aou Careggi - Firenze - Sod Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Firenze, Italy

Ao Di Cosenza, Presidio Ospedaliero Annunziata - Uoc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Cosenza, Italy

Ao Ospedali Riuniti "Papardo Piemonte" - Po Papardo - Messina - Sc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Messina, Italy

Irccs Ospedale S. Raffaele - Milano - Unitร  Neoplasie Linfocitarie B

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Italy

Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Italy

Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Italy

Aou Di Modena - Sc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Modena, Italy

Aou Maggiore Della Carita' Di Novara - Scdu Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Novara, Italy

Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo

๐Ÿ‡ฎ๐Ÿ‡น

Palermo, Italy

Aou Pisana - Uo Ematologia Universitaria

๐Ÿ‡ฎ๐Ÿ‡น

Pisa, Italy

Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo

๐Ÿ‡ฎ๐Ÿ‡น

Perugia, Italy

Ausl Della Romagna, Ospedale "Santa Maria Delle Croci" - Ravenna - Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Ravenna, Italy

Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Reggio Emilia, Italy

Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Reggio Calabria, Italy

Universitร  Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Roma, Italy

Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica

๐Ÿ‡ฎ๐Ÿ‡น

Roma, Italy

Ao S. Maria - Terni - Sc Onco Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Terni, Italy

Aou Cittร  Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Universitร  Degli Studi Di Torino

๐Ÿ‡ฎ๐Ÿ‡น

Torino, Italy

Asst Dei Sette Laghi, Ospedale Di Circolo E Fondazione Macchi - Uoc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Varese, Italy

Aou Cittร  Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2

๐Ÿ‡ฎ๐Ÿ‡น

Torino, Italy

Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia

๐Ÿ‡ฎ๐Ÿ‡น

Verona, Italy

ยฉ Copyright 2025. All Rights Reserved by MedPath